Back to News
Market Impact: 0.4
Vericel Q3 Earnings Call Highlights
Source: marketbeat.com
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Vericel raised its full-year revenue and profitability outlook after third-quarter sales increased 26%. Growth in its MACI cartilage repair product and a record quarter for its burn care business drove the gains.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
VCEL0.75
More News
- Truist raises Vericel stock price target on MACI growth momentum
- Further turmoil could be in store for tech stocks. What to watch in the week ahead
- Tech stock rout, driven by US AI fears, continues in Asian trading
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- AI stocks hammered by midterm shock as data center buildout becomes a 'war of attrition'
- Fox completes its $22B acquisition of Roku